“[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]”, FE, vol. 26, no. 1, Aug. 2025, doi: 10.7175/fe.v26i1.1581.